Abstract

Background: The purpose of this prospective study was to evaluate the efficacy and safety of the Ultrasound Cyclo Plasty (UCP) procedure using high-intensity focused ultrasound in surgery-naïve open-angle glaucoma patients. Methods: prospective, non-randomized, single-arm, multicenter clinical trial. Sixty-six eyes with primary open-angle glaucoma, intraocular pressure (IOP) ≥21 mmHg and with no history of filtering surgery were enrolled. Patients were treated by UCP with a therapy probe comprising six piezoelectric transducers, consecutively activated for 8 s each. Complete ophthalmic examination was performed before the procedure, 1 day after the procedure, and 1, 3, 6, 12, 18 and 24 months after the procedure. Primary outcomes were complete success (defined as IOP lowering from baseline ≥20% without additional glaucoma medications) and vision-threatening complications. Secondary outcomes were the presence of complications and the reduction of the number of medications used. Results: IOP was significantly reduced after one procedure (p < 0.05), from a mean pre-operative value of 24.3 ± 2.9 mmHg (n = 2.3 hypotensive medications) to a mean value of 15.9 ± 3.6 mmHg (n = 2.2 hypotensive medications) at 2 years (mean IOP lowering of 33%). Surgical success was achieved in 74% of eyes. Notwithstanding side effects such as transient anterior chamber inflammation, refractive error changes, transient hypotony and macular edema, no major intra or post-operative complications such as phthisis, induced cataract, neovascularization or significant vision loss were observed. Conclusions: Ultrasound Cyclo Plasty is a valuable, effective and well-tolerated procedure to lower IOP in patients with open-angle glaucoma without previous filtering surgery.

Highlights

  • Several animal studies and subsequent clinical studies have reported that high-intensity focused ultrasound (HIFU) is effective in terms of intraocular pressure (IOP) lowering in refractory glaucoma (38 to 42%) [7,8,9,10,11,12,13]

  • Functional in vivo studies have demonstrated the efficacy of coagulation of part of the ciliary body with HIFU

  • The study was conducted according to the principles defined in the Declaration of Helsinki and amendments, was approved by the ethics committee or institutional review board at each site (EC of Leuven: B322201629203; Lisboa EC: 78/16; EC of Tel-Aviv: N◦ 2917-16-SMC; EC of Pisa: ID 6942) and was registered on ClinicalTrials.gov (NCT02789293)

Read more

Summary

Introduction

Clinical studies have confirmed the tolerance and efficacy of the HIFU procedure This ultrasound treatment allows significant lowering of IOP (30–40%) without serious complications or major adverse effects [15,16,17,18,19,20,21]. The purpose of this study was to collect safety and efficacy data prospectively for 24 months after the Ultrasound Cyclo Plasty (UCP) treatment using HIFU with the EyeOP-1 in open-angle glaucoma patients without history of filtering surgery. The purpose of this prospective study was to evaluate the efficacy and safety of the Ultrasound Cyclo Plasty (UCP) procedure using high-intensity focused ultrasound in surgery-naïve open-angle glaucoma patients.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call